Targeting neuroinflammation to treat Alzheimer's disease
A Ardura-Fabregat, E Boddeke, A Boza-Serrano… - CNS drugs, 2017 - Springer
Over the past few decades, research on Alzheimer's disease (AD) has focused on
pathomechanisms linked to two of the major pathological hallmarks of extracellular …
pathomechanisms linked to two of the major pathological hallmarks of extracellular …
Microglia response during Parkinson's disease: alpha-synuclein intervention
SA Ferreira, M Romero-Ramos - Frontiers in cellular neuroscience, 2018 - frontiersin.org
The discovery of the central role played by the protein alpha-synuclein in Parkinson's
disease and other Lewy body brain disorders has had a great relevance in the …
disease and other Lewy body brain disorders has had a great relevance in the …
Outside in: Unraveling the Role of Neuroinflammation in the Progression of Parkinson's Disease
Neuroinflammation is one of the most important processes involved in the pathogenesis of
Parkinson's disease (PD). The current concept of neuroinflammation comprises an …
Parkinson's disease (PD). The current concept of neuroinflammation comprises an …
Origin and consequences of necroinflammation
M Sarhan, WG Land, W Tonnus… - Physiological …, 2018 - journals.physiology.org
When cells undergo necrotic cell death in either physiological or pathophysiological settings
in vivo, they release highly immunogenic intracellular molecules and organelles into the …
in vivo, they release highly immunogenic intracellular molecules and organelles into the …
Cell death pathways: a novel therapeutic approach for neuroscientists
In the first part, the following mechanisms involved in different forms of cell death are
considered, with a view to identifying potential therapeutic targets: tumour necrosis factor …
considered, with a view to identifying potential therapeutic targets: tumour necrosis factor …
High mobility group box 1 is a novel pathogenic factor and a mechanistic biomarker for epilepsy
T Ravizza, G Terrone, A Salamone, F Frigerio… - Brain, behavior, and …, 2018 - Elsevier
Approximately 30% of epilepsy patients experience seizures that are not controlled by the
available drugs. Moreover, these drugs provide mainly a symptomatic treatment since they …
available drugs. Moreover, these drugs provide mainly a symptomatic treatment since they …
Impact on the brain of the inflammatory response to surgery
S Saxena, M Maze - La Presse Médicale, 2018 - Elsevier
The brain is both the orchestrator as well as the target of the innate immune system's
response to the aseptic trauma of surgery. When trauma-induced inflammation is not …
response to the aseptic trauma of surgery. When trauma-induced inflammation is not …
Long-term hyperglycemia aggravates α-synuclein aggregation and dopaminergic neuronal loss in a Parkinson's disease mouse model
YQ Lv, L Yuan, Y Sun, HW Dou, JH Su, ZP Hou… - Translational …, 2022 - Springer
Background Growing evidence suggests an association between Parkinson's disease (PD)
and diabetes mellitus (DM). At the cellular level, long-term elevated levels of glucose have …
and diabetes mellitus (DM). At the cellular level, long-term elevated levels of glucose have …
The role of mitochondrial damage‐associated molecular patterns in chronic neuroinflammation
E Bajwa, CB Pointer, A Klegeris - Mediators of inflammation, 2019 - Wiley Online Library
Mitochondrial dysfunction has been established as a common feature of neurodegenerative
disorders that contributes to disease pathology by causing impaired cellular energy …
disorders that contributes to disease pathology by causing impaired cellular energy …
Neuroinflammatory paradigms in lysosomal storage diseases
ME Bosch, T Kielian - Frontiers in neuroscience, 2015 - frontiersin.org
Lysosomal storage diseases (LSDs) include approximately 70 distinct disorders that
collectively account for 14% of all inherited metabolic diseases. LSDs are caused by …
collectively account for 14% of all inherited metabolic diseases. LSDs are caused by …